B2M and cancer: Intrinsic cancer cell resistance represents loss of immunogenicity of cancer cells [40], which were suggested to result from alterations, such as loss of beta-2-microglobullin (B2M) function [41, 42] and phosphatase and tensin homolog deleted on chromosome 10 (PTEN) function [43].